SA PRO
Free Account
CervoMed Inc.CRVONASDAQ
LOADING
|||
OverviewChartsNewsFundamentalsEarningsAnalysts

Analyst Sentiment

Analysts lean bullish — 100% recommend buying.

Consensus Rating
Buy
7 analysts·Limited coverage
100%
Rating Distribution
Strong Buy
00%
Buy
7100%
Hold
00%
Sell
00%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Earnings & Revenue Estimates

Earnings Surprises

Recent Analyst Actions

Nov 5, 2025H.C. Wainwright
CervoMed upgraded to Buy from Neutral at H.C. Wainwright
Target:$25.00
+256.1%from $7.02
Oct 17, 2025Roth Capital
CervoMed price target raised to $20 from $16 at Roth Capital
Target:$20.00
+163.2%from $7.60
Aug 12, 2025Roth Capital
CervoMed price target lowered to $16 from $20 at Roth Capital
Target:$16.00
+70.0%from $9.41
Sep 18, 2024Loop Capital Markets
Chardan Capital Markets Starts CervoMed (CRVO) at Buy
Target:$55.00
+1048.2%from $4.79
Sep 18, 2024Chardan Capital
CervoMed initiated with a Buy at Chardan
Target:$55.00
+1048.2%from $4.79
Apr 8, 2024Canaccord Genuity
CervoMed (CRVO) PT Raised to $65 at Canaccord Genuity
Target:$65.00
+969.1%from $6.08

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance